Mutual ReleaseXenomics Inc • February 4th, 2009 • Biological products, (no disgnostic substances) • New York
Upon the occurrence of the Effective Date (as that term is defined in Section 4(a) of that certain Forbearance Agreement dated as of January 16, 2009 by and among Xenomics, Inc. and the holders of 6% convertible debenture notes (the “Forbearance Agreement”), Gian Luigi Buitoni (“Buitoni”), an individual residing in the State of New York, in consideration of the sum of TEN DOLLARS ($10.00), received from Xenomics, Inc. (the “Company”), a Florida corporation having offices located at One Deer Park Drive, Suite F, Monmouth Junction, New Jersey 08852, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, releases and discharges the Company, its officers, directors, subsidiaries, affiliates, successors and assigns, from all actions, causes of action, suits, liabilities, contracts, controversies, promises, damages, claims, and demands whatsoever, in law, at equity, known or unknown, suspected or unsuspected, which against the Company, its offic
FORBEARANCE AGREEMENTForbearance Agreement • February 4th, 2009 • Xenomics Inc • Biological products, (no disgnostic substances) • New York
THIS FORBEARANCE AGREEMENT (this “Agreement”) is made as of the 16th day of January, 2009, by and among XENOMICS, INC., a Florida corporation having offices located at One Deer Park Drive, Suite F, Monmouth Junction, New Jersey 08852 (the “Company”), and those holders of the “Debentures” (as that term is defined below) who have executed this Agreement (the “Undersigned Holders”). All of the holders of the Debentures are referred to herein collectively as the “Holders.”
